Press release
Alzheimer's Drugs Market Size Worth $9.8 Billion by 2027 | CAGR 6.21%
Alzheimer's disease (AD) is a chronic or persistent disorder that attacks the brain cells, affecting memory, thinking and behavior. Alzheimer's drugs refer to medications that help lessen symptoms, such as memory loss and confusion, for a limited time. These drugs also influence the functions of neurotransmitters, the chemicals involved in carrying messages between nerve cells in the brain.
Covid-19 Scenario:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download a free sample report to get a detailed overview of the report: https://www.imarcgroup.com/alzeimers-drugs-market/requestsample
Alzheimer's Drugs Market Trends:
The global Alzheimer's drugs market is primarily driven by the increasing number of people diagnosed with Alzheimer's disease. Besides this, the increasing prevalence of chronic diseases, such as diabetes, obesity, heart diseases and high blood pressure (BP), that increase the risk of Alzheimer's are contributing to the market. This is further supported by unhealthy dietary patterns, sedentary lifestyles and smoking, which are known to increase the chances of developing Alzheimer's disease. Moreover, several pharmaceutical companies are developing drugs that prevent the disease and provide long-lasting improvements in cognitive functions. The development of these drugs is anticipated to propel market growth in the coming years.
Global Alzheimer's Drugs Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
AbbVie (NYSE: ABBV), AstraZeneca PLC (AZN), Biogen Inc. (BIIB)., Daiichi Sankyo Company, Limited (DSNKY), Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/alzeimers-drugs-market
The report has segmented the market on the basis of Type, Thickness, Production Process, Application and Region.
By Drug Class:
Donepezil
Galantamine
Rivastigmine
Memantine
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Stores
Others
By Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Contact Us
30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Drugs Market Size Worth $9.8 Billion by 2027 | CAGR 6.21% here
News-ID: 2811146 • Views: …
More Releases from IMARC Group
Low VOC Adhesive Manufacturing Plant Setup Report 2025 | Industry Trends ,Raw Ma …
IMARC Group's "Low VOC Adhesive Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" report provides a comprehensive guide on how to successfully set up a low VOC adhesive manufacturing plant. The report offers clarifications on various aspects, such as unit operations, raw material requirements, utility supply, infrastructural needs, machinery models, labour necessities, transportation timelines, packaging costs, etc.
In addition to…
Hydrochloric Acid Manufacturing Plant Report- Project Cost, Setup Layout and Mac …
IMARC Group's "Hydrochloric Acid Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" report provides a comprehensive guide on how to successfully set up a hydrochloric acid manufacturing plant. The report offers clarifications on various aspects, such as unit operations, raw material requirements, utility supply, infrastructural needs, machinery models, labour necessities, transportation timelines, packaging costs, etc.
In addition to the operational…
Tertiary Butyl Alcohol Prices Surge in Q1 2025 Amid Crude Oil and Demand Rise
North America Tertiary Butyl Alcohol Prices Movement Q1:
Tertiary Butyl Alcohol Prices in USA:
In Q1 2025, Tertiary Butyl Alcohol Prices in the USA reached 1030 USD/MT in March. Rising crude oil prices due to global tensions and tight supply pushed TBA prices up. Seasonal fuel demand and growing regional interest also influenced market trends, leading to fluctuating prices during the quarter.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/tertiary-butyl-alcohol-pricing-report/requestsample
Note: The analysis can be…
Fire Alarms Manufacturing Plant Project Report 2025 | Unit Operations, Business …
Setting up a fire alarms manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Fire Alarms Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a fire…
More Releases for Alzheimer
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Alzheimer Diagnostic Tests Market
GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
